Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Gomez

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Biomolecular Structure & Dynamics|January 19, 2021
Rational design of PIN1 inhibitors for cancer treatment based on conformational diversity analysis and docking based virtual screeningJulián Maggio, Maia Cabrera, Romina Armando, et al.
Oncology Reports|March 24, 2023
Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma modelJulián Maggio, Georgina A Cardama, Romina G Armando, et al.
In Vivo (Athens, Greece)|March 27, 2003
Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1Mariana S de Lorenzo, Giselle V Ripoll, Hitoshi Yoshiji, et al.
Oncology Reports|February 12, 2002
Cancer vaccines: an update with special focus on ganglioside antigensRoberto J Bitton, Marcel D Guthmann, Mariano R Gabri, et al.
International Journal of Oncology|September 4, 2012
Telomere structure and telomerase in health and disease (review)Daniel E Gomez, Romina G Armando, Hernán G Farina, et al.
Oncotargets and Therapy|November 8, 2014
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cellsGeorgina A Cardama, Nazareno Gonzalez, Matias Ciarlantini, et al.
Clinical & Developmental Immunology|November 5, 2010
NGcGM3 ganglioside: a privileged target for cancer vaccinesLuis E Fernandez, Mariano R Gabri, Marcelo D Guthmann, et al.
International Journal of Molecular Medicine|April 22, 2008
Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patientsMariano R Gabri, Valeria Vazquez, Santiago Girón, et al.
Experimental Cell Research|May 14, 2011
CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivoHernán G Farina, Fernando Benavent Acero, Yasser Perera, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 27, 2013
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell linesGeorgina A Cardama, Maria J Comin, Leandro Hornos, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Biomolecular Structure & Dynamics|January 19, 2021
Rational design of PIN1 inhibitors for cancer treatment based on conformational diversity analysis and docking based virtual screeningJulián Maggio, Maia Cabrera, Romina Armando, et al.
Oncology Reports|March 24, 2023
Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma modelJulián Maggio, Georgina A Cardama, Romina G Armando, et al.
In Vivo (Athens, Greece)|March 27, 2003
Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1Mariana S de Lorenzo, Giselle V Ripoll, Hitoshi Yoshiji, et al.
Oncology Reports|February 12, 2002
Cancer vaccines: an update with special focus on ganglioside antigensRoberto J Bitton, Marcel D Guthmann, Mariano R Gabri, et al.
International Journal of Oncology|September 4, 2012
Telomere structure and telomerase in health and disease (review)Daniel E Gomez, Romina G Armando, Hernán G Farina, et al.
Oncotargets and Therapy|November 8, 2014
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cellsGeorgina A Cardama, Nazareno Gonzalez, Matias Ciarlantini, et al.
Clinical & Developmental Immunology|November 5, 2010
NGcGM3 ganglioside: a privileged target for cancer vaccinesLuis E Fernandez, Mariano R Gabri, Marcelo D Guthmann, et al.
International Journal of Molecular Medicine|April 22, 2008
Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patientsMariano R Gabri, Valeria Vazquez, Santiago Girón, et al.
Experimental Cell Research|May 14, 2011
CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivoHernán G Farina, Fernando Benavent Acero, Yasser Perera, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 27, 2013
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell linesGeorgina A Cardama, Maria J Comin, Leandro Hornos, et al.
Pageof 5